drugset / Trial / NCT01039194
Drug-Drug Interaction to Study the Effect of BMS-708163 on Pharmacokinetics (PK) of Galantamine Extended Release (ER)
Non-randomizedSingle-groupOpen-label
Summary
The purpose of the study is to find out if the plasma concentration of galantamine extended release is changed when BMS-708163 is administered at the same time.
Timeline
- Start
- 2010-01
- Primary completion
- 2010-04
- Completion
- 2010-04
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Avagacestat | Small molecule | 125 mg | Oral |
| Comparator | Galantamine | Small molecule | 16 mg | Oral |